Dr. Kara Kelly discusses some of the most common challenges faced by adolescent and young adult patients with lymphoma.

I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, ...

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...